
Oncologist

No OPD information available
Prostate Cancer
Prostatectomy
Anaplastic Thyroid Cancer
Desmoid Tumor
Fibromatosis
Head and Neck Squamous Cell Carcinoma (HNSCC)
Lung Cancer
Lung Metastases
Muscle Invasive Bladder Cancer
Proctitis
Spinal Tumor
Thyroid Cancer
Thomas N. Eade is a male medical professional who helps patients with various health issues like Prostate Cancer, Thyroid Cancer, Lung Cancer, and more. He is skilled in treating conditions such as Proctitis, Spinal Tumor, and Muscle Invasive Bladder Cancer.
Patients trust Thomas N. Eade because he communicates well with them, making sure they understand their conditions and treatment options. He stays updated with the latest medical knowledge and research to provide the best care possible.
Thomas N. Eade works closely with colleagues and other medical professionals, sharing knowledge and expertise to improve patient outcomes. His collaborative approach ensures that patients receive comprehensive and coordinated care.
Through his work, Thomas N. Eade has positively impacted many patients' lives by providing effective treatments and compassionate care. His research on exercise motivation in people with prostate cancer has been published in a respected medical journal, showing his commitment to advancing medical knowledge.
Thomas N. Eade is involved in various clinical trials, including studies on advanced techniques for radiotherapy in cancer treatment. These trials aim to improve treatment outcomes and quality of life for patients.
In summary, Thomas N. Eade is a dedicated and knowledgeable medical professional who uses his expertise to help patients with a range of health conditions. Through his commitment to staying updated with the latest research and his collaborative approach to patient care, he has made a significant impact on the lives of many individuals.
Enrollment Status: Recruiting
Published: April 06, 2025
Intervention Type: Radiation
Study Drug:
Study Phase: Not Applicable
Enrollment Status: Recruiting
Published: April 06, 2025
Intervention Type: Radiation
Study Drug:
Study Phase: Not Applicable
Enrollment Status: Recruiting
Published: December 18, 2024
Intervention Type: Radiation
Study Drug:
Study Phase: Not Applicable
